Advances in Stimuli-Responsive Peptide–Polymer Carriers for Mitochondrial Therapeutics
ACS Biomaterials Science & Engineering · 2026
DOI: 10.1021/acsbiomaterials.5c01513 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Biomaterials Science & Engineering, 2026. Verfasst von Puja Das Karmakar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Material Chemistry, Kyoto University, Katsura, Nishikyo-Ku, Kyoto 606-8501, Japan. Hauptthemen laut MEDLINE: Peptides, Mitochondria, Drug Carriers, Polymers. Die Arbeit nennt 121 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science, Japan Science and Technology Agency.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Material Chemistry, Kyoto University, Katsura, Nishikyo-Ku, Kyoto 606-8501, Japan.
- Biomacromolecules Research Team, RIKEN Center for Sustainable Resource Science, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan.
ORCID-Profile: Keiji Numata
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
Zitieren
APA
Das Karmakar, P., Odahara, M., & Numata, K. (2026). Advances in Stimuli-Responsive Peptide–Polymer Carriers for Mitochondrial Therapeutics. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c01513
Vancouver
Das Karmakar P, Odahara M, Numata K. Advances in Stimuli-Responsive Peptide–Polymer Carriers for Mitochondrial Therapeutics. ACS Biomaterials Science & Engineering. 2026. doi:10.1021/acsbiomaterials.5c01513
BibTeX
@article{DasKarmakar2026,
author = {Das Karmakar, Puja and Odahara, Masaki and Numata, Keiji},
title = {Advances in Stimuli-Responsive Peptide–Polymer Carriers for Mitochondrial Therapeutics},
journal = {ACS Biomaterials Science & Engineering},
year = {2026},
doi = {10.1021/acsbiomaterials.5c01513}
}
EUVIMED